Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
This study is ongoing, but not recruiting participants.
Study NCT01028651   Information provided by United Therapeutics

First Received on December 8, 2009.   Last Updated on April 9, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Portopulmonary Hypertension
Pulmonary Arterial Hypertension
Pulmonary Hypertension
Additional conditions recognized in this trial
Hypertension
Hypertension, Pulmonary
More general conditions related to this trial
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Treprostinil sodium
Additional drug interventions recognized in this trial
Treprostinil
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
United Therapeutics
University of California, Los Angeles
Brigham and Women's Hospital
University of Wisconsin, Madison
University of Texas
University of Kansas
Emory University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services